5/27/26 :: VROCKSTAR :: 
ZS
Tough spot but probs a buy
- mkt rippy but new lows for a lot of tape
- 20x EBITDA post print for 30% grower and '27 sandbagged? probably in the value region
- rule of 40 still passing, architectural and scale moat arguably (actually) expanded this quarter
- can't dislike the bonus points that this is founder-led. that's not lost on V
- Mythos tailwind incoming. Good way to play it.
- will be tracking. have wanted to re-engage cyber, but only a few names i like are way too expensive (and are everyone's favorites... and potentially see an additional unwind on results... so hard to neck on these based onZS print)
- what do u think anon?
- smol 50 delta calls for in july for exposure, would start to size if we see another leg down on a market/ beta wash in the coming sessions, would be good reversion trade. but it's juicy enough, for now for me to toe.
V
ZSTough spot but probs a buy
- mkt rippy but new lows for a lot of tape
- 20x EBITDA post print for 30% grower and '27 sandbagged? probably in the value region
- rule of 40 still passing, architectural and scale moat arguably (actually) expanded this quarter
- can't dislike the bonus points that this is founder-led. that's not lost on V
- Mythos tailwind incoming. Good way to play it.
- will be tracking. have wanted to re-engage cyber, but only a few names i like are way too expensive (and are everyone's favorites... and potentially see an additional unwind on results... so hard to neck on these based on
ZS print)- what do u think anon?
- smol 50 delta calls for in july for exposure, would start to size if we see another leg down on a market/ beta wash in the coming sessions, would be good reversion trade. but it's juicy enough, for now for me to toe.
V
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.